[Leptin treatment of multiple symmetric lipomatosis due to a mitochondrial defect]
Sigrid B Gribsholt1,2,3, Jens M Bruun1,3, Steen B Pedersen1,3
1Steno Diabetes Center Aarhus, Aarhus Universitetshospital.
Ugeskrift for Laeger
|May 7, 2026
Abstract:
Multiple symmetric lipomatosis, or Madelung's disease, is a rare condition with symmetrical fat deposits on the upper body, increasingly associated with genetic mutations. In this case report, we present a patient with an mitofusin 2 mutation causing mitochondrial dysfunction and extremely low leptin. Treatment with metreleptin led to reduced appetite, 17% weight loss, improved triglyceride levels, insulin sensitivity, and reduced liver fat. This is the first published Danish case; metreleptin shows promising results in the treatment of rare leptin-deficient lipodystrophic disorders.

